http://www.minoryx.com/ 2026-03-27 weekly http://www.minoryx.com/clinical-studies/ 2026-03-27 weekly http://www.minoryx.com/our-science-overview/ 2026-03-27 weekly http://www.minoryx.com/our-pipeline-overview/ 2026-03-27 weekly http://www.minoryx.com/news/ 2026-03-27 weekly http://www.minoryx.com/our-company/ 2026-03-27 weekly http://www.minoryx.com/careers/ 2026-03-27 weekly http://www.minoryx.com/adrenoleukodystrophy-orphan-disease/ 2026-03-27 weekly http://www.minoryx.com/friedreich-ataxia-orphan-disease/ 2026-03-27 weekly http://www.minoryx.com/legal-notice/ 2026-03-27 weekly http://www.minoryx.com/privacy-policy/ 2026-03-27 weekly http://www.minoryx.com/cookies-policy/ 2026-03-27 weekly http://www.minoryx.com/management-team/ 2026-03-27 weekly http://www.minoryx.com/funding/ 2026-03-27 weekly http://www.minoryx.com/leriglitazone/ 2026-03-27 weekly http://www.minoryx.com/contact/ 2026-03-27 weekly http://www.minoryx.com/board-directors/ 2026-03-27 weekly http://www.minoryx.com/clinical-studies/clinical-study-advance/ 2026-03-27 weekly http://www.minoryx.com/clinical-studies/clinical-study-frames/ 2026-03-27 weekly http://www.minoryx.com/clinical-studies/clinical-study-nexus/ 2026-03-27 weekly http://www.minoryx.com/clinical-studies/resources/ 2026-03-27 weekly http://www.minoryx.com/politica-privacidad/ 2026-03-27 weekly http://www.minoryx.com/clinical-studies/expanded-access-policy/ 2026-03-27 weekly http://www.minoryx.com/clinical-studies/clincal-study-calyx/ 2026-03-27 weekly http://www.minoryx.com/scientific-publications/ 2026-03-27 weekly http://www.minoryx.com/media/leriglitazone_maa_submitted_for_treatment_of_cald_has_been_validated_by_ema/ 2025-07-23 weekly http://www.minoryx.com/media/minoryx_receives_a_eur_26.9m_grant_within_the_framework_of_the_european_ipcei_med4cure_project/ 2025-07-17 weekly http://www.minoryx.com/media/results_from_nexus_interim_analysis_published_in_eclinicalmedicine/ 2025-06-04 weekly http://www.minoryx.com/media/minoryx-announces-dosing-of-the-first-patient-with-leriglitazone-in-the-phase-2a-study-in-rett-syndrome/ 2025-03-03 weekly http://www.minoryx.com/media/leriglitazone_has_met_the_primary_endpoint_in_nexus/ 2024-12-11 weekly http://www.minoryx.com/media/leriglitazone_halts_disease_progression_in_adult_patients_with_early_cerebral_adrenoleukodystrophy_in_compassionate-use_study_published_in_brain/ 2024-06-11 weekly http://www.minoryx.com/media/update_on_regulatory_review_of_nezglyal_in_the_eu/ 2024-05-31 weekly http://www.minoryx.com/media/rare_disease_day_2024_special_film_launched/ 2024-02-29 weekly http://www.minoryx.com/media/update_on_regulatory_review_of_leriglitazone_in_the_eu/ 2024-01-26 weekly http://www.minoryx.com/media/minoryx_announces_enrollment_of_first_patients_with_cerebral_adrenoleukodystrophy_in_us_phase_3_clinical_trial_calyx/ 2023-11-16 weekly http://www.minoryx.com/media/minoryx-gains-fda-approval-to-initiate-a-phase-3-clinical-trial-in-patients-with-cerebral-adrenoleukodystrophy/ 2023-05-31 weekly http://www.minoryx.com/media/minoryx-presents-positive-interim-results-from-nexus/ 2023-04-25 weekly http://www.minoryx.com/media/the-lancet-neurology-publishes-results-from-minoryx-therapeutics-phase2-3-advance-clinical-trial-of-leriglitazone-in-x-linked-adrenoleukodystrophy/ 2023-01-20 weekly http://www.minoryx.com/media/leriglitazone’s-clinical-proof-of-concept-data-in-friedreich’s-ataxia-published-in-neurology-genetics/ 2023-01-18 weekly http://www.minoryx.com/media/minoryx-and-neuraxpharm-announce-a-strategic-alliance-to-provide-a-new-therapy-for-rare-cns-disease-patients-in-europe/ 2022-11-09 weekly http://www.minoryx.com/media/minoryxs-marketing-authorization-application-for-its-lead-candidate-leriglitazone-validated-by-ema-for-orphan-indication-x-linked-adrenoleukodystrophy-(x-ald)/ 2022-09-14 weekly http://www.minoryx.com/media/minoryx-raises-e51-million-to-support-marketing-authorization-application-and-launch-preparations-for-x-linked-adrenoleukodystrophy-(x-ald)-therapy/ 2022-05-30 weekly http://www.minoryx.com/media/additional-data-from-minoryx’s-phase-2-3-advance-clinical-trial-presented-at-american-neurological-association-(ana)-2021/ 2021-11-02 weekly http://www.minoryx.com/media/minoryx_publishes_mechanism_of_action_of_leriglitazone_in_x-ald_in_science_translational_medicine_journal/ 2021-06-03 weekly http://www.minoryx.com/media/minoryx_phase_2-3_advance_study_results_to_be_presented_at_the_2021_aan_annual_meeting/ 2021-04-12 weekly http://www.minoryx.com/media/minoryx_presents_topline_results_from_phase_2-3_“advance”_study_demonstrating_significant_clinical_benefit_of_leriglitazone_in_adrenomyeloneuropathy_(amn)/ 2021-01-25 weekly http://www.minoryx.com/media/minoryx’s_clinical_candidate_leriglitazone_shows_clinical_benefit_in_a_proof_of_concept_phase_2_study_in_friedreichs_ataxia/ 2020-12-15 weekly http://www.minoryx.com/media/minoryx’s_preclinical_data_for_leriglitazone_in_friedreich’s_ataxia_published_in_neurobiology_of_disease_journal/ 2020-11-16 weekly http://www.minoryx.com/media/european-investment-bank-provides-minoryx-with-up-to-e25-million/ 2020-10-30 weekly http://www.minoryx.com/media/minoryx-therapeutics-and-sperogenix-therapeutics-enter-into-an-exclusive-license-agreement-to-develop-and-commercialize-leriglitazone-in-mainland-china-hong-kong-and-macau/ 2020-09-23 weekly http://www.minoryx.com/media/minoryx-therapeutics-doses-first-patient-with-leriglitazone-in-registration-enabling-cald-nexus-trial/ 2020-05-12 weekly http://www.minoryx.com/media/minoryx-therapeutics-receives-us-fda-fast-track-designation-for-leriglitazone-in-the-treatment-of-x-ald/ 2020-01-09 weekly http://www.minoryx.com/media/minoryx-therapeutics-receives-orphan-drug-designation-from-the-european-commission-for-leriglitazone-in-the-treatment-of-friedreichs-ataxia/ 2019-11-13 weekly http://www.minoryx.com/media/minoryx-therapeutics-receives-fda-orphan-drug-designation-for-leriglitazone-in-friedreichs-ataxia/ 2019-10-17 weekly http://www.minoryx.com/media/minoryx-therapeutics-to-participate-in-upcoming-investor-conferences/ 2019-10-14 weekly http://www.minoryx.com/media/minoryx_therapeutics_completes_enrollment_in_frames_phase_2_trial_with_leriglitazone_in_friedreichs_ataxia/ 2019-10-08 weekly http://www.minoryx.com/media/minoryx_announces_first_patient_dosed_in_the_frames_phase_2_trial_in_friedreichs_ataxia/ 2019-06-04 weekly http://www.minoryx.com/media/minoryx_appoints_didier_le_normand_as_group_chief_financial_officer_and_general_manager_of_its_belgian_subsidiary/ 2019-03-12 weekly http://www.minoryx.com/media/minoryx_therapeutics_receives_approval_from_spanish_regulatory_agency_to_initiate_phase_2_study_in_friedreichs_ataxia/ 2019-02-27 weekly http://www.minoryx.com/media/minoryx-therapeutics-extends-its-activities-in-belgium/ 2019-01-15 weekly http://www.minoryx.com/media/minoryx_therapeutics_-announces_early_completion_of_patient_randomization/ 2018-12-13 weekly http://www.minoryx.com/media/minoryx-therapeutics-raises-e21-3m-in-series-b-funding-round/ 2018-09-26 weekly http://www.minoryx.com/media/a-consortium-led-by-minoryx-receives-0-8m-to-explore-additional-indications-for-min-102/ 2018-09-21 weekly http://www.minoryx.com/media/minoryx-therapeutics-announces-dosing-of-first-us-patient-in-phase-23-clinical-study-of-min-102-advance/ 2018-09-05 weekly http://www.minoryx.com/media/minoryx-therapeutics-spins-off-see-tx-platform-new-company-gain-therapeutics/ 2018-02-20 weekly http://www.minoryx.com/media/minoryx-therapeutics-announces-dosing-first-patient-advance-phase-23-clinical-study-min-102-patients-adrenomyeloneuropathy-amn/ 2018-01-04 weekly http://www.minoryx.com/media/minoryx-therapeutics-successfully-completes-phase-1-clinical-trial-for-lead-candidate-min-102/ 2017-03-21 weekly http://www.minoryx.com/media/minoryx-therapeutics-receives-orphan-drug-designation-from-the-us-fda-for-its-lead-candidate-min-102/ 2017-02-22 weekly http://www.minoryx.com/media/dr-claude-nicaise-joins-minoryx-therapeutics-as-independent-board-member/ 2017-02-07 weekly http://www.minoryx.com/media/minoryx-therapeutics-further-strengthens-its-scientific-advisory-board-sab/ 2017-01-18 weekly http://www.minoryx.com/media/shadows-a-picture-from-natalia-perez-wins-the-2nd-edition-of-one-day-at-the-pcb/ 2016-12-23 weekly http://www.minoryx.com/media/minoryx-fbg-and-csic-are-awarded-with-a-grant-from-spanish-government-for-identifying-pharmacological-chaperones-for-lysosomal-storage-disorders/ 2016-12-16 weekly http://www.minoryx.com/media/minoryx-therapeutics-receives-european-orphan-drug-designation-for-its-lead-candidate-min-102-part2/ 2016-12-14 weekly http://www.minoryx.com/media/minoryx-receives-senen-vilaro-award-as-the-most-innovative-spin-out-from-the-university-of-barcelona/ 2016-11-25 weekly http://www.minoryx.com/media/minoryx-participates-in-ammic-a-platform-to-develop-new-therapies-for-rare-diseases/ 2016-10-10 weekly http://www.minoryx.com/media/minoryx-therapeutics-initiates-phase-1-clinical-trial-of-min-102/ 2016-07-06 weekly http://www.minoryx.com/media/minoryx-therapeutics-appoints-dr-uwe-meya-as-chief-medical-officer/ 2016-06-14 weekly http://www.minoryx.com/media/minoryx-receives-innovative-sme-certificate/ 2016-06-14 weekly http://www.minoryx.com/media/minoryx-awarded-with-bioexit-2015/ 2016-03-11 weekly http://www.minoryx.com/media/rare-diseases-day-2016/ 2016-02-29 weekly http://www.minoryx.com/media/minoryx-therapeutics-appoints-dr-khalid-islam-as-chairman-of-the-board-of-directors/ 2016-01-27 weekly http://www.minoryx.com/media/minoryx-team-runs-for-rare-diseases/ 2015-10-18 weekly http://www.minoryx.com/media/minoryx-therapeutics-completes-series-a-funding-of-e19-4m-21-7m/ 2015-10-14 weekly http://www.minoryx.com/media/meet-us-at-bioeurope-2015/ 2015-10-14 weekly http://www.minoryx.com/media/meet-us-at-bioequity-2015/ 2015-05-13 weekly http://www.minoryx.com/media/health-equity-enters-into-minoryxs-captial-with-0-75me/ 2015-04-09 weekly http://www.minoryx.com/media/minoryx-joins-rare-diseases-day-initiative/ 2015-03-10 weekly http://www.minoryx.com/media/rare-diseases-day-2015/ 2015-02-25 weekly http://www.minoryx.com/media/minoryx-raises-1-6me-in-a-round-led-by-caixa-capital-risc/ 2015-01-23 weekly http://www.minoryx.com/media/run-for-rare-diseases-at-cursa-per-lesperanca/ 2014-10-08 weekly http://www.minoryx.com/media/minoryx-among-the-10-start-up-to-watch-in-catalonia/ 2014-07-21 weekly http://www.minoryx.com/media/minoryx-releases-introductory-video-on-non-competitive-pharmacological-chaperones/ 2014-07-21 weekly http://www.minoryx.com/media/minoryx-joins-a-consortium-focused-on-the-treatment-and-diagnostics-of-inborn-errors-of-metabolism/ 2014-06-14 weekly http://www.minoryx.com/media/meet-us-at-biovision-2014/ 2014-06-04 weekly http://www.minoryx.com/media/biocentury-highlights-minoryx-as-emerging-company/ 2014-04-27 weekly http://www.minoryx.com/media/minoryx-receives-orphan-drug-designation-for-min-101/ 2014-04-03 weekly http://www.minoryx.com/media/minoryx-supports-feder-the-spanish-federation-of-rare-diseases/ 2014-02-13 weekly http://www.minoryx.com/media/rare-disease-day-2014/ 2014-02-13 weekly http://www.minoryx.com/media/meet-us-at-bioeurope-2013/ 2013-10-29 weekly http://www.minoryx.com/media/the-minister-for-health-from-the-catalan-government-receives-minoryx-to-learn-about-its-progress/ 2013-10-09 weekly http://www.minoryx.com/media/minoryx-supports-the-1st-iberoamerican-alliance-for-rare-diseases/ 2013-10-08 weekly http://www.minoryx.com/media/morato-l-et-al-pioglitazone-halts-axonal-degeneration-in-a-mouse-model-of-x-linked-adrenoleukodystrophy/ 2013-08-19 weekly http://www.minoryx.com/media/minoryx-to-participate-at-international-congress-of-inborn-errors-of-metabolism-iciem-2013/ 2013-08-19 weekly http://www.minoryx.com/media/minoryx-to-participate-at-1st-world-conference-on-congenital-disorders-of-glycosylation-for-families-and-professionals/ 2013-08-16 weekly http://www.minoryx.com/media/minoryx-licenses-a-patent-from-idibell-of-a-product-to-treat-x-linked-adrenoleukodystrophy/ 2013-08-05 weekly http://www.minoryx.com/media/aymami-j-et-al-pharmacological-chaperones-for-enzyme-enhancement-therapy-in-genetic-diseases/ 2013-08-01 weekly http://www.minoryx.com/media/minoryx-awarded-by-emprendedorxxi-catalunya-as-the-innovative-start-up-with-the-highest-growth-potential/ 2013-06-06 weekly http://www.minoryx.com/media/la-caixa-and-inveready-invest-in-minoryx/ 2013-04-02 weekly http://www.minoryx.com/media/minoryx-participates-on-a-web-documentary-about-rare-diseases/ 2013-02-28 weekly http://www.minoryx.com/media/pharmaceutical-patent-analyst-publishes-a-review-about-pharmacological-chaperones-authored-by-minoryx/ 2013-02-01 weekly http://www.minoryx.com/media/the-eurotransbio-consortium-re-mark-raredis-led-by-minoryx-rare-partners-and-cisi-has-been-selected-for-receiving-funds-to-investigate-on-drug-repositioning-in-rare-diseases/ 2013-01-07 weekly http://www.minoryx.com/media/minoryxs-ceo-participates-as-panelist-at-the-orphan-cns-diseases-session-at-bio-europe-spring/ 2013-01-03 weekly http://www.minoryx.com/media/a-consortium-led-by-minoryx-receives-2-3me-for-developing-pharmacological-chaperones-for-the-treatment-of-two-rare-metabolic-diseases/ 2012-12-21 weekly http://www.minoryx.com/media/minoryx-interviewed-by-diari-ara/ 2012-11-18 weekly http://www.minoryx.com/media/minoryx-interviewed-by-el-punt-avui/ 2012-11-17 weekly http://www.minoryx.com/media/nigel-ten-fleming-joins-minoryx-as-chairman/ 2012-10-25 weekly http://www.minoryx.com/media/minoryx-receives-best-presentation-award-at-biochem-accelerator-forum-biospain-2012-bilbao/ 2012-09-21 weekly http://www.minoryx.com/media/minoryx-to-chair-day-1-in-world-drug-repositioning-congress-2012/ 2012-08-29 weekly http://www.minoryx.com/media/minoryx-licenses-technology-from-ub-and-icrea-to-develop-a-new-generation-of-pharmacological-chaperones/ 2012-08-29 weekly http://www.minoryx.com/media/minoryx-receives-a-participative-loan-from-enisa-jovenes-emprendedores/ 2012-01-27 weekly http://www.minoryx.com/media/minoryx-awarded-at-bancaja-jovenes-emprendedores/ 2011-12-27 weekly http://www.minoryx.com/media/caixa-capital-risc-invests-into-minoryx-through-its-initial-investment-vehicle-caixacapitalmicro-scr/ 2011-12-27 weekly http://www.minoryx.com/media/minoryx-awarded-with-the-3rd-prize-at-best-business-plan-catalunya-2011/ 2011-12-02 weekly http://www.minoryx.com/media/minoryx-awarded-as-2nd-finalist-at-bioemprenedorxxi/ 2011-11-24 weekly